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Abstract 
Preeclampsia is associated with structural/functional alterations in placental and maternal 
vasculature. KV7 (voltage-dependant potassium channels encoded by KCNQ1-5 genes) 
have been detected in several types of blood vessels where they promote vascular 
relaxation. KV7 channel function can be modulated by KCNE1-5 encoded accessory 
proteins. The aim of this study was to determine whether KCNQ and KCNE genes are 
differentially expressed in placentae from women with preeclampsia compared to 
normotensive controls and to examine any differences in those who delivered preterm 
(<37 weeks’) or term. Placental biopsies (from midway between the cord and periphery) 
were obtained, with consent, from White European control (n=24, term) and preeclamptic 
(n=22; of whom 8 delivered before 37 weeks’) women. KCNQ/KCNE and GAPDH 
mRNA expression was determined by qRT-PCR. Protein expression/localisation was 
assessed using immunohistochemistry. KCNQ3 and KCNE5 mRNA expression was 
significantly up-regulated in preeclampsia (median [IQR]: 1.942 [0.905, 3.379]) versus 
controls (0.159 [0.088, 0.288]; p=0.001) and exhibited a strong positive correlation with 
each other (p<0.001) suggesting a novel heterodimer. Enhanced protein expression of 
KCNQ3 and KCNE5 in preeclampsia was confirmed with localisation mainly restricted 
to the syncytiotrophoblast. KCNQ4 and KCNE1 isoforms were suppressed in placenta 
from term preeclamptic women versus controls (p≤0.05). KCNQ1 mRNA expression was 
increased and KCNQ5 decreased in the preterm preeclamptic group versus controls 
(p<0.05). In summary, KV7 channels are expressed and markedly modulated in placenta 
from preeclamptic women. Differential expression of isoforms may lead to altered cell 
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proliferation. The correlation between KCNQ3 and KCNE5 expression is indicative of a 
novel channel complex and warrants further investigation.  
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Introduction 
Preeclampsia is a pregnancy-specific condition affecting 2-7% of women and is 
associated with maternal multi-organ dysfunction1.  This disorder, which is responsible 
for approximately 60,000 maternal deaths each year worldwide2, increases perinatal 
mortality five-fold3 and is commonly associated with preterm delivery and fetal growth 
restriction4. Women who develop preeclampsia and their babies are at increased risk of 
hypertension, metabolic disorders, cardiovascular disease and cardiovascular death in 
later life5, 6.  
 
The pathophysiology underpinning the disorder is complex. Impaired placentation almost 
certainly plays a part. Placental and maternal oxidative stress  and generalised systemic 
inflammatory activation7 are main components of the syndrome8. Altered maternal and 
placental vascular reactivity and endothelial cell function have been implicated in the 
clinical manifestations of preeclampsia, e.g. an increase in total peripheral vascular 
resistance (TPVR) 9, 10, hypertension and altered haemodynamics.  
 
There is emerging evidence to suggest that potassium channels play important roles in the 
feto-placental vasculature 11-15. Specifically, it is proposed that suppression of KV channel 
function may increase vascular tone and hence be a mechanism affecting perfusion in 
placentae from women with preeclampsia.    
 
The sub-family of voltage gated KV7 channels (potassium channel complexes encoded by 
KCNQ1-5 and KCNE1-5 genes) are of particular interest, as preliminary data indicate the 
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presence of functional KV7 channels in human chorionic plate arteries
15. KV7 channel 
activity is generally associated with outwardly rectifying, voltage dependent, K+ 
currents16. KV7 channels have been identified in numerous blood vessels including 
human visceral and mesenteric arteries17, and the cerebral, carotid, femoral and 
mesenteric arteries of rodents as well as the aorta and portal vein18-20 where they appear 
to play a role in vascular reactivity. A potential role for these channels in pulmonary 
hypertension has also been reported21. KV7 channels are also important in non-excitable 
cells such as epithelia22-24 and in regulation of cell volume25 and ion transport (Cl-, Na+) 
across epithelia22, 23. In skeletal muscle myoblasts, KCNQ5 has been implicated in cell-
cycle progression and cellular proliferation and differentiation26; but this appears to have 
been less well studied in vascular smooth muscle. KV channel dysfunction has previously 
been linked to abnormalities in proliferation and possibly also to remodelling27.  The 
presence of KV7 channels in placenta and relative expression in blood vessels, 
endothelium and syncytiotrophoblast is unknown and the expression profiles in placenta 
from normotensive and preeclamptic women have not been determined.    
 
The aim of this study, therefore, was to establish KCNQ/KCNE mRNA expression 
profiles in placentae taken from women with preeclampsia both at term and preterm as 
well as normotensive controls and confirm regulation and localisation by 
immunohistochemistry.  
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Materials and Methods  
Human Placental Tissue Collection 
Subjects 
The study population consisted of White European women who had either a 
normotensive or preeclamptic pregnancy (Table 1)28.  The investigations were approved 
by the Nottingham Hospital Ethics Committee and written, informed consent was 
obtained from each participant.  Cases were defined on admission with a clinical 
diagnosis of preeclampsia, using the International Society for the Study of Hypertension 
in Pregnancy (ISSHP) definition of systolic blood pressure of 140 mm Hg or more and 
diastolic pressure (Korotkoff V) of 90 mm Hg or more on 2 occasions after 20 weeks 
gestation in a previously normotensive woman, together with proteinuria of ≥300 mg/L, 
≥500 mg/day or ≥2+ on dipstick analysis of midstream urine (MSU) if 24-hour collection 
result was not available29.  Medical and obstetric histories, including delivery data, were 
obtained for each woman. The birthweight centile for each baby was computed, 
correcting for gestation age, sex, maternal parity and body mass index (BMI) 30.  Doppler 
velocimetry measurements are not routinely made with preeclampsia in our hospital.  
 
Sample collection  
Placental tissue samples were collected from all subjects at a standardised location 
midway between cord insertion and placental border, avoiding placental infarcts. The 
placental samples were taken within 10 minutes of delivery; the membranes were 
removed and tissue washed in ice cold 1 x PBS to remove maternal blood contamination. 
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One sample was snap frozen in liquid nitrogen and stored at -80oC for RNA analysis and 
another formalin fixed and wax-embedded for immunohistochemical analysis. 
RNA extraction and cDNA synthesis 
 
Total RNA (n=22 pre-eclamptics and n=24 normotensive controls) was extracted from a 
known amount of placental tissue (between 50 to 100 mg) using QIAzol lysis reagent 
(Qiagen, Crawley, UK). RNA concentration and quality were verified by gel 
electrophoresis and spectrophotometrically using the Nanodrop ND-1000 (Nanodrop 
Technologies, Labtech, Ringmer, UK); all samples had an A260/A280 ratio greater than 
1.96 and were stored at −80 °C. RNA (1 µg) was then reverse transcribed using the 
QuantiTect Reverse Transcription Kit containing a mix of random primers and Oligo dT 
(Qiagen, Crawley, UK) in a Primus 96 advanced gradient thermocycler (Peqlab Ltd, 
Fareham, UK). The conditions used to generate first strand cDNA were 42 °C (15 min) 
and 95 °C (3 min).  
 
Quantitative RT-PCR 
Real-time PCR was carried out with the use of SYBR Green chemistry (2 x Sensimix; 
Bioline, UK) on a RotorGene 6000 (Corbett Research, Australia) using the primers listed 
in Table 2. A pre-PCR cycle was run for 15 min at 95°C followed by 45 cycles of 95°C 
for 15 s, 60°C for 30 s and 72°C for 20 s. Melt-curve analysis was performed to confirm 
the presence of one single product and non-template controls (NTCs) run to assess 
contamination. Cycle threshold (CT) values were used for analysis and abundance data 
was obtained by the use of quantified cDNA to generate a standard curve. Standards were 
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quantified using densitometry and 10 fold serial dilutions (109 to 101 copies) run in 
parallel with the samples. Abundance data for the genes of interest were expressed to 
GAPDH, a stably expressed housekeeping gene, suitable for human placental samples31. 
 
Immunohistochemistry 
Serial sections of placental tissue were cut (5 μm) in the same orientation from paraffin-
embedded tissue blocks (Sledge Microtome, Anglia Scientific, Norwich, UK) and 
mounted onto Superfrost plus glass microscope slides (Menzel-Glaser, Braunschweig, 
Germany). Before use, sections were dewaxed by immersion in xylene followed by 
rehydration in descending concentrations of alcohol (3 min each). 
 
Immunohistochemical staining was performed using the Vector Stain Elite ABC kit 
(Vector Laboratories, US).  Two goat polyclonal antibodies (KCNQ3 and KCNE5, 
SantaCruz Biotechnologies) were employed for immunostaining of paraffin-embedded 
placental sections (n=6 preeclamptic and n=6 normotensive controls). The optimal 
dilution for each antibody was established by performing a dilution series, with final 
selection on the basis of maximal specific reactivity and minimal background staining. 
Heat induced epitope retrieval was achieved by heating in a citrate buffer (pH 6.0) using 
a microwave oven for 15 min followed by incubation for 30 min in normal donkey serum 
(Vector Laboratories, US) to block non-specific binding. Slides were then incubated with 
either anti-KCNQ3 (1:50) or anti-KCNE5 (1:50) overnight at 4oC. A positive control 
(human mid-brain) was used to verify specificity. A negative control was performed for 
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each test section by incubation with goat IgG. Sections were dehydrated and cleared in 
ascending concentrations of alcohol and xylene before mounting in DPX (BDH, UK).  
 
All slides were assessed by the same observer, blinded to pregnancy outcome. For 
analysis of placental sections, digital images of 5 randomly selected high-power (x400 
magnification) fields were captured on NIS-Elements F2.20 microscope (Nikon UK Ltd, 
Surrey, UK). Quantification of KCNQ3 and KCNE5 were performed as previously 
described 32, using the Positive Pixel Algorithm of Aperio ImageScope software. This 
software is able to discriminate between positive and negative stained pixels, and 
combines the number of positive pixels stained with the intensity of these same pixels to 
produce the value ‘positivity’. A visual check was also performed to ensure accurate 
discrimination of immunolabelled regions.  
 
Statistical analysis  
We determined that a sample of 22 preeclamptic and 24 normal controls would provide 
93% power to detect a difference of 1.25 SD in changes in gene expression with 
Bonferroni multiple testing. All tests were performed using SPSS for Windows version 
16.0.  The Kolmogorov-Smirnov test was used to test for normality of data distribution 
and summary data are presented as means ± SD or median [interquartile range (IQR)] as 
appropriate for data distribution.  Between-group comparisons were made using 2-tailed 
Student’s t tests/ or Mann-Whitney U-tests depending on the distribution. To assess 
association between mRNA expression of KCNQ and KCNE forms, data were 
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normalised using log10. Visual inspection suggested a curvilinear association which was 
tested by regression analysis.  The null hypothesis was rejected where P < 0.05.   
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Results 
Subjects 
Table 1 describes the demographic, obstetric and pregnancy data of the 46 women who 
participated in the study; further clinical details are published28.  All women conceived 
naturally and carried singleton pregnancies.  The normotensive group gave birth without 
developing hypertension or proteinuria, to infants weighing > 2500 g, delivered at 37 
weeks or later.  The systolic and diastolic blood pressure levels were, by definition, 
significantly raised in preeclampsia compared to normal pregnancy (p<0.0001).  Overall, 
the preeclamptic women all had moderate to severe disease and had lower gestational 
ages at delivery than the control group (p<0.05) (Table 1). No preeclamptic woman had 
HELLP (Hemolysis Elevated Liver enzymes, and Low Platelet count) or required 
magnesium sulphate administration. All neonates from both pregnancy groups survived.   
 
KCNQ/KCNE expression in placentae from normotensive control versus all preeclamptic 
women 
The expression of KCNQ and KCNE isoforms in placental tissue from normotensive 
controls (n=24) and women with preeclampsia (n=22), as determined by qRT-PCR is 
shown in Figure 1. The relative abundance of placental tissue KCNQs expression in both 
control and preeclamptic groups was KCNQ3 > KCNQ5> KCNQ2> KCNQ1> KCNQ4. 
mRNA for KCNQ3 (Figure 1A) was significantly higher in preeclampsia (median [IQR]: 
0.02 [0.01, 0.06] vs. 470 [236, 1148], p<0.0001) while that for KCNQ5 (Figure 1A) was 
down-regulated in tissues from preeclamptic women compared to controls (0.02 [0.006, 
0.06] vs. 0.8 [0.3, 0.2], p<0.005).  
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All KCNE isoforms were detected in placental tissue in both control and preeclamptic 
groups (KCNE5> KCNE1= KCNE3> KCNE4> KCNE2). However, KCNE5 mRNA 
expression (Figure 1B) was significantly up-regulated in preeclampsia, compared to 
control samples (1.94 [0.91, 3.38] vs. 0.16 [0.09, 0.29], p<0.0001). 
 
Association of expression of KCNQ3 and KCNE5 
The substantial fold increases in both KCNQ3 and KCNE5 mRNA copy number in 
preeclamptic placental tissues, was further examined and a highly significant positive, 
curvilinear association between KCNQ3 and KCNE5 mRNA expression was 
demonstrated (in preeclamptic placentae (Figure 2; ●) r=0.96; R2=0.93; p<0.0001). a 
significant association was also observed, at a much lower level of expression, in tissues 
from normotensive controls (r=0.73; R2=0.54; p<0.05; ∆).  
   
 
Placental expression of KCNQ/KCNE in normotensive (term), preterm and term 
preeclampsia 
Due to the significant difference between the gestational ages in the control versus 
preeclamptic cohorts (Table 1), the preeclamptic group was further subdivided into those 
who had delivered preterm (<37 weeks; n = 8) and those who delivered at term (n = 14).  
Placental KCNQ1 was significantly (p<0.05) up-regulated in preterm labour versus 
normotensive controls (Figure 3A,) while KCNQ5 was significantly suppressed in 
placenta from preeclamptic women delivering preterm versus normotensive controls 
(Figure 3A; p<0.001). KCNQ4 (Figure 3A) and KCNE1 (Figure 3B) were significantly 
down regulated in the preeclamptic group at term versus controls (p<0.05). KCNQ5 was 
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also significantly down-regulated in the preterm, but not term preeclamptic group 
compared to controls (Figure 3A; p<0.001). Interestingly, both KCNQ3 and KCNE5 
were significantly increased in preeclamptic placentae delivered at both preterm and term 
compared to the normotensive controls (Figure 3A and 3B, p<0.001).  There was no 
significant difference in placental expression of any KCNQ or KCNE isoform when 
comparing a small subgroup (n= 5) of women with preeclampsia with fetal growth 
restriction to the remaining preeclamptic women (n=17, p >0.05).   
 
KCNQ3 and KCNE5 encoded protein localisation and expression in control versus 
preeclamptic placentae 
Given the observed differences in mRNA expression for KCNQ3 and KCNE5, we 
performed immunohistochemistry, to determine protein localization and expression. 
Positive expression of both KCNQ3 and KCNE5 was seen in placental tissue from both 
groups in syncytiotrophoblast cells and in stromal areas, with little expression in the 
vasculature. Quantification of positive staining revealed that the expression was 
significantly increased in preeclampsia versus normotensive controls (Figure 4) for both 
KCNQ3 (p=0.041) and KCNE5 (p=0.015).  
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Discussion 
This study has established KV7 channel isoform expression profiles in human placental 
tissue.  To our knowledge, this is the first description of altered K+ channel expression 
(involving both α and β subunits) in the placenta of women with preeclampsia. These 
novel data add to a nascent body of literature concerning K+ channels and their role in 
placental function14, and is important given the widespread impact mutations of KV7 
channels have on human health (e.g. cardiac arrhythmias, epilepsy, and deafness)16. The 
implications of our data are likely to be multifaceted due to the complex functions of the 
placenta and the specific KV7 formation
 channels involved. Altered KV7 channel 
expression could impact on many areas of placental function including vascular tone, 
placental proliferation, ion transport or even steroidogenesis.  
 
Our data demonstrates specific up-regulation of KCNQ3 and KCNE5 in placenta from 
women with preeclampsia and a highly statistically-significant association between them 
(Figure 2) suggesting the presence of a novel heterodimer (see below). It has been 
suggested that a majority of KCNQ3 channels exist in a silent state33. We speculate that a 
stimulus associated with pre-eclampsia may lead to activation of these channels, thus 
enhancing their function. This up-regulation appears most relevant to preeclamptic 
women as KCNQ3 and KCNE5 remain significantly up-regulated in both term and 
preterm preeclampsia when compared to normotensive controls. A functional 
polymorphism (KCNQ3-A315T) has been reported markedly to increase trafficking of 
KCNQ3 subunits from the endoplasmic reticulum to the cell surface and to increase their 
stability in neuronal tissue34. This polymorphism appears not to have been studied in the 
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placenta or vascular tissue. Other isoforms, KCNQ1, KCNQ4, KCNQ5 and KCNE1 are 
also differentially modulated in term and preterm preeclampsia. One explanation for 
these gestation-related differences could be linked to severity of disease in those who 
deliver at earlier gestations.  
 
The statistically significant association between KCNQ3 and KCNE5 expression in 
tissues from preeclamptic women (Figure 2) could suggest that they may form a novel 
heterodimeric channel complex. There are no published reports of this channel 
composition existing in other tissues, but individually, each isoform has been shown to 
have a range of functions when coupled to other proteins. KCNQ3 along with KCNQ2 
and/or KCNQ5 encodes for a channel that underlies the M current, which is important in 
determining the sub-threshold excitability of neurones35, 36. KCNQ3 along with KCNQ5 
is highly expressed in bladder smooth muscle37. KCNE5 is highly expressed in femoral 
artery20 and can modulate KCNQ1 encoded channels with respect to the voltage and 
time-dependent functions of the channel38.  Such channel complex specific activity makes 
it difficult to predict how different KV7 channels may influence placental/vascular 
function. However, we hypothesise that the observed up-regulation of KCNQ3 and 
KCNE5 would encode for a KV7 channel subtype that promotes a greater outward 
potassium current. In this way, alteration in KV7 channel isoforms could be viewed as a 
compensatory mechanism rather than a primary event responsible for reduced placental 
perfusion. The observation that KCNQ2/KCNQ3 encoded channels have also recently 
been shown to be inhibited by angiotensin II may also be relevant as our group and others 
have reported that there is an increased vascular responsiveness to angiotensin II in 
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preeclampsia39-41. The importance of KV7 channels to vascular reactivity has also been 
repeatedly demonstrated 18, 20. 
 
Immunohisotchemistry data also provides some insight into the potential impact of 
altered KV7 channel composition. The distribution of KCNQ3 and KCNE5 protein was 
not as localised to vascular regions as might be expected. The greatest protein density 
was detected in syncytiotrophoblast, which may indicate that placental KV7 channels are 
related to cell proliferation, angiogenesis or solute transport. Indeed, KV7 channels have 
been shown to mediate Na+ and Cl- transport across other types of epithelia22, 23 and other 
K+ channels; TASK1 and TASK-2 expressed in placental trophoblast cells are proposed 
to play a role in regulating syncytiotrophoblast homeostasis and/or solute transport13.  It 
would be interesting to also determine the expression levels of Kv7 channels in tissues 
from early pregnancy, particularly in relation to the extravillous trophoblast. Additional 
novel data obtained by Milan et al. (2010) suggests that K+ channels are involved in 
placental steroidogenesis via their contribution to mitochondrial K+ concentrations. This 
opens up a further avenue of investigation in the role KV7 channels may play in the 
placenta which may also include cell proliferation, since K+ channels have previously 
been linked to cell proliferation42. Future experiments should aim to determine the 
channel complexes present and the functional role of KV7 channels in syncytiotrophoblast 
proliferation and migration and placental vascular reactivity.  
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Perspectives 
The marked upregulation of KCNQ3 and KCNE5 KV7 channels in preeclamptic 
placentae, and their strong association, indicates a potential role for KV7 channels in the 
aetiology of preeclampsia. This warrants further investigation into the roles KV7 may 
play in syncytiotrophoblast and other placental cell function such as trophoblast 
proliferation and migration, as well as, possibly, vascular reactivity. Their modulation 
and diversity may make them an interesting target for potential therapeutics to treat 
hypertension.  
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Figure Legends 
Figure 1. A) KCNQ and B) KCNE mRNA expression in placentae from women with 
preeclampsia (PE, n=22) versus normotensive controls (NC, n=24). Data is expressed 
as median [IQR] normalised to GAPDH. Note the substantial change of scale for KCNQ3 
and KCNE5.KCNQ3 and KCNE5 were significantly up-regulated in PE versus NC, 
whereas KCNQ5 expression was suppressed in PE. (* p<0.05, ** p<0.001).  
 
Figure 2. Scatter plot demonstrating the association between KCNQ3 and KCNE5 
mRNA expression in preeclamptic placentae.  Signifcant curvilinear associations were 
seen between KCNQ3 and KCNE5 expression in tissues from women with preeclampsia 
(r=0.96; R2=0.93; p<0.0001; ●), and normotensive controls, although at a much lower 
level of expression (r=0.73; R2=0.54; p<0.05;∆).  
 
Figure 3. A) KCNQ and B) KCNE mRNA expression in placentae from women with 
preterm (n=8) and term (n=14) preeclampsia (PE) versus normotensive controls 
(NC, n=24). Data is expressed as median [IQR] normalised to GAPDH. KCNQ3 and 
KCNE5 expression was significantly up-regulated in both preterm and term PE placentae. 
KCNQ1 expression was increased in preterm PE alone, whereas KCNQ4 and KCNE1 
were down-regulated in term samples. KCNQ5 expression was significantly decreased in 
preterm PE samples only (* p<0.05, ** p<0.001). 
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Figure 4. Expression of A) KCNQ3 and B) KCNE5 encoded proteins in placentae 
from women with preeclampsia (PE, n=6) versus normotensive controls (NC, n=6). 
KCNQ3 and KCNE5 expression was significantly up-regulated in PE placentae (A2/B2) 
versus normotensive controls (A1/B1). Positive staining was localised mainly to stromal 
areas and syncytiotrophoblast (black arrow). Some staining was detected in blood vessels 
(white arrow). Data is expressed as median [IQR], arbitrary units.  x 400 magnification, 
positive controls (human midbrain) are shown in panels A3/B3 and negative controls in 
A4/B4 (* p<0.05, ** p<0.001). 
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Parameter 
Normotensive  
(n = 24) 
Preeclampsia 
(n = 22) 
Maternal age (years) 30 ± 7.0 32 ± 6.0  
Primipara  14 (58%) 15 (65%) 
Booking body mass index (Kg/m2) 26.2 ± 5.3 26.8 ± 4.7 
Max. systolic blood pressure 
outside labour (mmHg) 116 ± 5.0 157 ± 8.0 † 
Max. diastolic blood pressure 
outside labour (mmHg) 76 ± 3.0 98 ± 4.0 † 
Proteinuria (g/L)  - 1.0 [0.4, 1.7] 
Gestation age at delivery (weeks) 
No of deliveries < 37 weeks 
40.1 ± 1.2 
0 
36.8 ± 3.6 † 
8 (36%) 
Caesarean section  4 (16.6%) 8 (16.6%) * 
Birthweight (Kg) 3.51 [3.25, 3.76] 3.14 [2.14, 3.52] † 
Birthweight centile  45 [23, 65] 35 [3, 82] 
 
Table 1. Demographic, pregnancy, clinical and biochemical data of subject groups.  
Data are presented as mean ± SD or median [IQR] as appropriate, except for proteinuria: 
[median (min, max)] and parity, Caesarean sections and no of deliveries < 37 weeks 
[number (percentage)]. These are a subgroup of our previous publication28.  *P < 0.05,  
† P < 0.001, between normal and pre-eclamptic pregnancies.    
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Gene Accession number                  Primers 
Length 
(bp) 
KCNQ1 NM_000218.2 
5'-catcacccacatctcacagc-3' 
124 5'-gtcccgcacatcgtaagg-3' 
 
KCNQ2 NM_004518.3 
5'-gacaaggaccgcaccaag-3' 
123 5'-caccaggaagtccagcttct-3' 
 
KCNQ3 NM_004519.2 
5'-cgagtttgctttgaggatctg-3' 
119 5'-aggcaatcagcacaaagatgt-3' 
 
KCNQ4 NM_004700.2 
5'-tgccccctcagaggaagt-3' 
119 5'-ccaccaggaacttgagaatcc-3' 
 
KCNQ5 NM_019842.2 
5'-agtcccaccaaagtgcaga-3' 
120 5'-agtgccaagggctgtgtc-3' 
 
KCNE1 NM_000219.2 
5'-gtcctttgatgcaagggtcta-3' 
123 5'-ctggtctcttcctcctgagc-3' 
 
KCNE2 NM_172201.1 
5'-atcctgcccacacactgc-3' 
114 5'-cgccaattgtccatataagtaataaaa-3' 
 
KCNE3 NM_005472.4 
5'-tccagagacatcctgaagagg-3' 
123 5'-ggggaagactcggtagaagc-3' 
 
KCNE4 NM_080671.1 
5'-cctcttggactggacgattt-3' 
107 5'-gtgctgttcagaggctccat-3' 
 
KCNE5 NM_012282.2 
5'-aactctgggccgtctaactg-3' 
113 
5'-aaggcaactggaagctgga-3' 
GAPDH NM_002046.3 
5'-ggaagcttgtcatcaatggaa-3' 
102 
5'-tggactccacgacgtactca-3'  
 
Table 2. Primers used in qPCR. 
 
 
 
